![Christopher Chapman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Chapman
No open positions remaining
Profile
Christopher C.
Chapman was the founder of Chapman Pharmaceutical Health Foundation, founded in 2006, serving as Chairman from 2006 to 2024.
Dr. Chapman was the founder of Telomir Pharmaceuticals, Inc., founded in 2021, serving as Chairman & Chief Executive Officer from 2022 to 2024.
Dr. Chapman is also the founder of Chapman Pharmaceutical Consulting, Inc...
Former positions include Executive Chairman at MIRA Pharmaceuticals, Inc. from 2023 to 2024; Medical Director at Regeneron Pharmaceuticals, Inc. from 1992 to 1994; President & Director at Rock Creek Pharmaceuticals, Inc. from 2013 to 2015; Director at BioVest International, Inc. in 2004; Independent Director at Accentia Biopharmaceuticals, Inc. from 2012 to 2013; Associate Director-Drug Safety & Pharmacovigilance at Organon Pharmaceuticals USA, Inc. from 2003 to 2004; Executive Director-Medical Affairs at IQVIA RDS Consulting, Inc. from 1995 to 2003; President, Director & Chief Medical Officer at Q from 2021 to 2024; and President & Chief Medical Officer at MyMD Pharmaceuticals (Florida), Inc. from 2020 to 2021.
Education includes a doctorate from Georgetown University School of Medicine conferred in 1987 and an undergraduate degree from Harvard Kennedy School of Government conferred in 2020.
Former positions of Christopher Chapman
| Companies | Position | End |
|---|---|---|
Chapman Pharmaceutical Consulting, Inc.
 Chapman Pharmaceutical Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides medical consulting services for the development of pharmaceutical and medical devices | Chief Executive Officer | 11/08/2024 |
Chapman Pharmaceutical Health Foundation | Founder | 11/08/2024 |
| TELOMIR PHARMACEUTICALS, INC. | Chief Executive Officer | 11/08/2024 |
| Q/C TECHNOLOGIES, INC. | Chief Executive Officer | 14/04/2021 |
| MIRA PHARMACEUTICALS, INC. | Chairman | 08/03/2024 |
Training of Christopher Chapman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Rock Creek Pharmaceuticals, Inc.
 Rock Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures a variety of pharmaceutical products | Health Technology |
BioVest International, Inc.
 BioVest International, Inc. Medical SpecialtiesHealth Technology Develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers | Health Technology |
Accentia Biopharmaceuticals, Inc.
 Accentia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceuticals | Health Technology |
Chapman Pharmaceutical Consulting, Inc.
Chapman Pharmaceutical Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides medical consulting services for the development of pharmaceutical and medical devices | Commercial Services |
Chapman Pharmaceutical Health Foundation | |
Organon Pharmaceuticals USA, Inc.
 Organon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Markets and distributes pharmaceutical products | Health Technology |
IQVIA RDS Consulting, Inc.
 IQVIA RDS Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides global regulatory, compliance, and validation consulting services | Commercial Services |
Harvard Kennedy School of Government
 Harvard Kennedy School of Government Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University School of Medicine
 Georgetown University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MyMD Pharmaceuticals (Florida), Inc.
 MyMD Pharmaceuticals (Florida), Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops therapeutic platforms | Health Technology |
MyMD Pharmaceuticals, Inc.
 MyMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that engages in the development of drug products to extend healthy lifespan | Health Technology |
MIRA Pharmaceuticals, Inc.
 MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
Telomir Pharmaceuticals, Inc.
 Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
- Stock Market
- Insiders
- Christopher Chapman
